Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QBX258 in moderate to severe asthma
NCT01479595Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2012
- Primary completion
- Feb 2015
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of dectrekumab in asthma, sponsored by Novartis. Started Feb 2012; status: completed.
02
Drugs
dectrekumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01479595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479595.